In this study, AMA in Japan was found to be associated with a significantly higher maternal mortality rate than pregnancies at a younger age. Previous studies have also reported that an increase in maternal age is associated with an increase in various obstetric complications and maternal mortality (9-11). The results of the present study are similar to those previously reported.
Although the comorbidity of chronic diseases such as malignant, cardiovascular, and renal diseases is increased in AMA (12), their involvement as a cause of death was low. The most common cause of death in the AMA group in this study was hemorrhagic stroke. The association of hemorrhagic stroke, rather than stroke, with maternal mortality is a problem unique to Asian populations (13, 14), and more than half of the deaths due to hemorrhagic stroke were associated with gestational hypertensive nephropathy. In general, the incidence of gestational hypertensive nephropathy is reported to be 3-4% but increases to 5-10% in those 40-49 years of age and to 35% in those >50 years of age (15). In addition, at ≥40 years, the relative risk of mortality was reported to be 1.68 (95% CI, 1.23-1.39) for first-time mothers (16). It is clear that the incidence of gestational hypertensive nephropathy is increased in AMA, especially in pregnant older Japanese and Asian women, and adequate attention should be paid to the development of hemorrhagic stroke due to gestational hypertensive nephropathy during pregnancy. When restricted to Asian populations, uterine artery Doppler, angiogenesis factors, and aspirin therapy should be used to monitor and prevent the occurrence of hypertensive nephropathy in pregnant women >40 years old.
Among assisted reproductive therapies, frozen-thawed embryo transfer and egg donation in particular have been reported to be risk factors for preeclampsia (17, 18). In the present study, the proportion of women who had undergone assisted reproductive medical treatment and those with mortality at age ≥ 40 years was low. In addition, there were no cases of maternal mortality due to hemorrhagic stroke caused by gestational hypertensive nephropathy among those who had undergone assisted reproductive therapy-induced pregnancy. The proportion of assisted reproductive technology-induced pregnancies in Japan is expected to increase in the future, as increasing age increases the dependence on assisted reproductive technology. Therefore, it is important to be aware of the possibility of developing gestational hypertensive nephropathy after the use of assisted reproductive technology.
In addition to hemorrhagic stroke, pulmonary thromboembolism, infectious diseases, cardiovascular diseases, and suicide significantly increased maternal mortality in older pregnant women. This also suggests that we should not focus solely on hemorrhagic stroke.
In Japan, the maternal mortality rate in women <20 years of age was low. In the United Kingdom, the maternal mortality rate among pregnant women aged 20-29 years is the lowest, and the maternal mortality rates for pregnancies among those <20 years of age and ≥30 years increase compared to those among pregnant women in their 20s (3). This is the major difference between Japan and other countries. Japan has a lower rate of pregnancies in women under the age of 20 years compared to other countries. In addition, Japan provides generous medical insurance coverage to all citizens regardless of the financial status. During pregnancy, women are given a medical checkup slip almost free of charge and can visit a hospital every four weeks in the first trimester, every two weeks in the second trimester, and every week in the last trimester of pregnancy. In addition to the Japanese health care system, the racial groups enrolled in this study were almost exclusively Japanese, which provides a background that is less prone to biases other than age.
The limitations of this study include, first, that it is a mono-ethnic study and does not adjust for maternal mortality owing to several confounding factors, although the Japanese insurance system provides a background for the uniform provision of medical care. Second, although we have detailed data on deaths, we do not have detailed data on survivors. Third, we did not have information on hospital sources, infrastructure, and staff that contribute to maternal mortality and risk. It is not possible to determine whether high-risk women benefit from being in a particular healthcare setting. Fourth, because of the relatively low maternal mortality rates, the denominators for some of the groups were relatively small, making it impossible to make meaningful comparisons between the groups in terms of mortality rates.
In conclusion, increasing age is proportional to maternal mortality in Japan. In particular, the mortality rate is 2.3 times higher for those aged ≥40 years than for those aged 35-39 years. In addition, hemorrhagic stroke is the most common cause of maternal mortality among those aged ≥ 40 years, and more than half of hemorrhagic strokes are associated with gestational hypertensive nephropathy. These facts should be considered by women who become pregnant at an advanced age and by healthcare providers involved in their perinatal care.